Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geir Bredholt

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)Cecilie Totland, Geir Bredholt, Mette Haugen, et al.
Endocrinology|February 25, 2006
The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitopeEystein S Husebye, Eirik Bratland, Geir Bredholt, et al.
The Journal of Infectious Diseases|September 13, 2012
A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccinationRishi Delan Pathirana, Geir Bredholt, Per Espen Akselsen, et al.
Journal of Autoimmunity|March 31, 2009
The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's diseaseEirik Bratland, Geir Bredholt, Gunnar Mellgren, et al.
The Journal of Infectious Diseases|January 12, 2013
Reply to SambharaGeir Bredholt, Gabriel Kristian Pedersen, Rishi Delan Pathirana, et al.
NPJ Vaccines|December 19, 2017
Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccinationSarah M Tete, Florian Krammer, Sarah Lartey, et al.
Cancers|July 9, 2022
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of ImmunotherapiesKatrin Kleinmanns, Stein-Erik Gullaksen, Geir Bredholt, et al.
Plos One|November 10, 2011
Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMPGabriel Kristian Pedersen, Thomas Ebensen, Ingrid Hjetland Gjeraker, et al.
The Journal of Infectious Diseases|November 27, 2014
Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in childrenKristin G-I Mohn, Geir Bredholt, Karl A Brokstad, et al.
European Journal of Endocrinology|January 10, 2004
Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1Anette S Bøe, Geir Bredholt, Per M Knappskog, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)Cecilie Totland, Geir Bredholt, Mette Haugen, et al.
Endocrinology|February 25, 2006
The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitopeEystein S Husebye, Eirik Bratland, Geir Bredholt, et al.
The Journal of Infectious Diseases|September 13, 2012
A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccinationRishi Delan Pathirana, Geir Bredholt, Per Espen Akselsen, et al.
Journal of Autoimmunity|March 31, 2009
The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's diseaseEirik Bratland, Geir Bredholt, Gunnar Mellgren, et al.
The Journal of Infectious Diseases|January 12, 2013
Reply to SambharaGeir Bredholt, Gabriel Kristian Pedersen, Rishi Delan Pathirana, et al.
NPJ Vaccines|December 19, 2017
Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccinationSarah M Tete, Florian Krammer, Sarah Lartey, et al.
Cancers|July 9, 2022
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of ImmunotherapiesKatrin Kleinmanns, Stein-Erik Gullaksen, Geir Bredholt, et al.
Plos One|November 10, 2011
Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMPGabriel Kristian Pedersen, Thomas Ebensen, Ingrid Hjetland Gjeraker, et al.
The Journal of Infectious Diseases|November 27, 2014
Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in childrenKristin G-I Mohn, Geir Bredholt, Karl A Brokstad, et al.
European Journal of Endocrinology|January 10, 2004
Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1Anette S Bøe, Geir Bredholt, Per M Knappskog, et al.
Pageof 3